Suppr超能文献

新型α1基因突变Hb Pak Num Po与α0地中海贫血的共同遗传与依赖输血的血红蛋白H病相关。

Co-inheritance of Hb Pak Num Po, a novel alpha1 gene mutation, and alpha0 thalassemia associated with transfusion-dependent Hb H disease.

作者信息

Viprakasit Vip, Tanphaichitr Voravarn S, Veerakul Gavivann, Chinchang Worrawut, Petrarat Siripan, Pung-Amritt Parichat, Higgs Douglas R

机构信息

Department of Pediatrics and Siriraj-Thalassemia Research Program, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

出版信息

Am J Hematol. 2004 Mar;75(3):157-63. doi: 10.1002/ajh.10479.

Abstract

Hb H disease is generally associated with moderate to severe anemia but rarely requires regular blood transfusion. We recently studied two apparently unrelated patients with transfusion-dependent Hb H disease. Hemoglobin studies demonstrated Hb H and Hb Bart's without other detectable abnormal globin species. Extensive molecular analyses of the alpha globin genes and their regulatory sequence (HS-40) revealed that both patients are compound heterozygotes for alpha0 thalassemia (--(SEA)) and a novel point mutation, a thymidine insertion after codon 131 of the alpha1 gene. The resulting frameshift gives rise to a highly unstable alpha globin chain, which we refer to as "Hb Pak Num Po," containing an additional 34 amino acids. This unusual alpha1 globin variant clearly causes alpha thalassemia, but the unexpectedly severe phenotype suggests that this mutation may have additional effects on red cell physiology. A PCR-based (ARMS) assay was developed for rapid detection of this novel mutation, and this might be useful to study the prevalence of this novel mutation which poses potentially significant clinical consequences in populations of Southeast Asia. Detecting carriers of this mutation using the molecular diagnostic procedures described will provide the means to screen and prevent a potentially severe form of alpha thalassemia in Thailand.

摘要

血红蛋白H病通常与中度至重度贫血相关,但很少需要定期输血。我们最近研究了两名明显无关的依赖输血的血红蛋白H病患者。血红蛋白研究显示存在血红蛋白H和血红蛋白巴特,未检测到其他异常球蛋白种类。对α珠蛋白基因及其调控序列(HS-40)进行的广泛分子分析表明,两名患者均为α0地中海贫血(--(SEA))和一种新的点突变的复合杂合子,该点突变是α1基因第131密码子后插入了一个胸腺嘧啶。由此产生的移码导致产生一种高度不稳定的α珠蛋白链,我们将其称为“血红蛋白Pak Num Po”,它含有另外34个氨基酸。这种不寻常的α1珠蛋白变体显然导致了α地中海贫血,但出乎意料的严重表型表明该突变可能对红细胞生理学有额外影响。开发了一种基于聚合酶链反应(ARMS)的检测方法来快速检测这种新突变,这可能有助于研究这种新突变在东南亚人群中的流行情况,该突变可能具有潜在的重大临床后果。使用所述分子诊断程序检测该突变的携带者将为在泰国筛查和预防一种潜在严重形式的α地中海贫血提供手段。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验